oxandrolone has been researched along with Growth Disorders in 67 studies
Oxandrolone: A synthetic hormone with anabolic and androgenic properties.
Growth Disorders: Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oxandrolone (Ox) increases height gain but may also cause voice deepening in growth hormone (GH)-treated girls with Turner syndrome (TS)." | 9.15 | The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome. ( Boersma, B; de Muinck Keizer-Schrama, SM; de Ridder, MA; Dejonckere, PH; Menke, LA; Otten, BJ; Sas, TC; van Koningsbrugge, SH; Wit, JM; Zandwijken, GR, 2011) |
| "Oxandrolone (Ox) increases height gain but may also cause voice deepening in growth hormone (GH)-treated girls with Turner syndrome (TS)." | 5.15 | The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome. ( Boersma, B; de Muinck Keizer-Schrama, SM; de Ridder, MA; Dejonckere, PH; Menke, LA; Otten, BJ; Sas, TC; van Koningsbrugge, SH; Wit, JM; Zandwijken, GR, 2011) |
| "This randomized, placebo-controlled trial demonstrates that low-dose oxandrolone can increase both height and weight velocity in boys with delayed puberty safely." | 5.08 | Oxandrolone therapy in constitutionally delayed growth and puberty. Bio-Technology General Corporation Cooperative Study Group. ( Brown, DR; Dudley, R; McCauley, E; Wilson, DM, 1995) |
| "The linear growth effects of oxandrolone, human growth hormone, and Ox + hGH were compared in six girls, age 11 to 15 years, with X chromosome abnormalities (three with X,O karyotype, three with Turner syndrome variants)." | 5.05 | Effect of growth hormone and oxandrolone singly and together on growth rate in girls with X chromosome abnormalities. ( Blackston, D; Goldsmith, M; Kutner, M; Rudman, D, 1980) |
| " The addition of oxandrolone to growth hormone (GH) in Turner syndrome has an additive effect on adult height gain." | 4.91 | Novel approaches to short stature therapy. ( Oostdijk, W; Wit, JM, 2015) |
| "Girls with Turner's syndrome aged 7-13 years at recruitment, receiving recombinant growth hormone therapy (10 mg/m(2)/week)." | 2.76 | Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial. ( Betts, P; Casey, S; Cole, TJ; Donaldson, MD; Dunger, DB; Gault, EJ; Hindmarsh, PC; Paterson, WF; Perry, RJ, 2011) |
| "Oxandrolone is a safe and effective treatment for prepubertal boys with constitutional growth delay." | 2.67 | Treatment of constitutional growth delay in prepubertal boys with a prolonged course of low dose oxandrolone. ( Papadimitriou, A; Pearl, K; Preece, MA; Stanhope, R; Wacharasindhu, S, 1991) |
| " There is a dose-response relationship." | 2.38 | [Growth hormone treatment in short stature of unknown origin]. ( Wit, JM, 1992) |
| "Children with Turner's syndrome will not have the same growth response as children who have classical growth hormone insufficiency." | 2.38 | Treatment of growth hormone insufficiency. ( Hindmarsh, PC, 1990) |
| "Oxandrolone has an androgenic action as shown by changes in serum LH, testosterone and SHBG concentrations and by the lack of effect on FSH." | 1.29 | The effects of oxandrolone on the growth hormone and gonadal axes in boys with constitutional delay of growth and puberty. ( Brook, CG; Hindmarsh, PC; Malhotra, A; Poon, E; Pringle, PJ; Tse, WY, 1993) |
| " Our data suggest that 6 months-1 year, low dosage oxandrolone treatment in constitutionally delayed growth has no significant effect on the pattern of pubertal growth, nor on the rate of sexual maturation or on final height." | 1.29 | Oxandrolone in constitutional delay of growth: analysis of the growth patterns up to final stature. ( Bassi, F; Cheli, D; Gheri, RG; Neri, AS; Serio, M, 1993) |
| "The oxandrolone-treated boys were divided into two groups: four boys who received oxandrolone before onset of puberty (group 2), and 14 boys who started oxandrolone therapy during Tanner stage 2 (group 3)." | 1.29 | The effect of prolonged administration of an anabolic steroid (oxandrolone) on growth in boys with constitutionally delayed growth and puberty. ( Delemarre-van de Waal, HA; Knibbe, P; Schroor, EJ; van Weissenbruch, MM, 1995) |
| "Eleven patients with Turner's syndrome aged 12." | 1.28 | Growth hormone treatment in Turner's syndrome: short and long-term effects on metabolic parameters. ( Frisch, H; Haeusler, G, 1992) |
| "Forty-eight girls with Turner's syndrome were assigned to one of three treatments; recombinant human growth hormone (rhGH) alone, rhGH plus oxandrolone, and rhGH plus ethinyloestradiol." | 1.28 | Effect of recombinant human growth hormone therapy on bone and clinical parameters in girls with Turner's syndrome. The Spanish Collaborative Group. ( Anton, R; Arnal, JM; Buñuel, C; Ferrández, A; García, C; Lasarte, JJ; Mayayo, E; Puyuelo, P, 1989) |
| "An adolescent with stunted growth was treated for 6 months with a synthetic anabolic androgen." | 1.27 | Focal nodular hyperplasia associated with the use of a synthetic anabolic androgen. ( Alberti-Flor, JJ; Iskandarani, M; Jeffers, L; Schiff, ER; Zeppa, R, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 32 (47.76) | 18.7374 |
| 1990's | 25 (37.31) | 18.2507 |
| 2000's | 4 (5.97) | 29.6817 |
| 2010's | 6 (8.96) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, DB | 1 |
| Cuttler, L | 1 |
| Wit, JM | 3 |
| Oostdijk, W | 1 |
| Herndon, DN | 1 |
| Voigt, CD | 1 |
| Capek, KD | 1 |
| Wurzer, P | 1 |
| Guillory, A | 1 |
| Kline, A | 1 |
| Andersen, CR | 1 |
| Klein, GL | 1 |
| Tompkins, RG | 1 |
| Suman, OE | 1 |
| Finnerty, CC | 1 |
| Meyer, WJ | 1 |
| Sousse, LE | 1 |
| Salehpour, S | 1 |
| Alipour, P | 1 |
| Razzaghy-Azar, M | 1 |
| Ardeshirpour, L | 1 |
| Shamshiri, A | 1 |
| Monfared, MF | 1 |
| Gharib, A | 1 |
| Menke, LA | 1 |
| Sas, TC | 1 |
| van Koningsbrugge, SH | 1 |
| de Ridder, MA | 1 |
| Zandwijken, GR | 1 |
| Boersma, B | 1 |
| Dejonckere, PH | 1 |
| de Muinck Keizer-Schrama, SM | 1 |
| Otten, BJ | 1 |
| Gault, EJ | 1 |
| Perry, RJ | 1 |
| Cole, TJ | 1 |
| Casey, S | 1 |
| Paterson, WF | 1 |
| Hindmarsh, PC | 5 |
| Betts, P | 1 |
| Dunger, DB | 1 |
| Donaldson, MD | 1 |
| Lampit, M | 1 |
| Hochberg, Z | 1 |
| Ramos, AV | 1 |
| Silva, IN | 1 |
| Goulart, EM | 1 |
| Vuković, D | 1 |
| Alberti-Flor, JJ | 1 |
| Iskandarani, M | 1 |
| Jeffers, L | 1 |
| Zeppa, R | 1 |
| Schiff, ER | 1 |
| Kelley, VC | 2 |
| Ruvalcaba, RH | 1 |
| Novoa Mogollón, J | 1 |
| Salto Hernández, L | 1 |
| Pérez Pérez, C | 1 |
| Alcáñiz Ferrando, J | 1 |
| Uriarte Arana, A | 1 |
| Moreno Puertas, C | 1 |
| Barceló Lucerga, B | 1 |
| Romshe, CA | 1 |
| Sotos, JF | 1 |
| Rudman, D | 1 |
| Goldsmith, M | 1 |
| Kutner, M | 1 |
| Blackston, D | 1 |
| Jones, RW | 1 |
| El Bishti, MM | 1 |
| Bloom, SR | 1 |
| Burke, J | 1 |
| Carter, JE | 1 |
| Counahan, R | 1 |
| Dalton, RN | 1 |
| Morris, MC | 1 |
| Chantler, C | 2 |
| Wilson, DM | 2 |
| McCauley, E | 1 |
| Brown, DR | 1 |
| Dudley, R | 1 |
| Albanese, A | 3 |
| Stanhope, R | 9 |
| Frasier, SD | 1 |
| Lippe, BM | 2 |
| Kelnar, CJ | 2 |
| Kewley, GD | 1 |
| Long, A | 1 |
| Pearl, KN | 1 |
| Robins, DG | 1 |
| Malhotra, A | 1 |
| Poon, E | 1 |
| Tse, WY | 2 |
| Pringle, PJ | 2 |
| Brook, CG | 5 |
| Saenger, P | 1 |
| Wu, FC | 1 |
| Brown, DC | 1 |
| Butler, GE | 1 |
| Stirling, HF | 1 |
| Bassi, F | 1 |
| Neri, AS | 1 |
| Gheri, RG | 1 |
| Cheli, D | 1 |
| Serio, M | 1 |
| Schroor, EJ | 1 |
| van Weissenbruch, MM | 1 |
| Knibbe, P | 1 |
| Delemarre-van de Waal, HA | 1 |
| Crowne, EC | 1 |
| Wallace, WH | 1 |
| Moore, C | 1 |
| Mitchell, R | 1 |
| Robertson, WH | 1 |
| Holly, JM | 1 |
| Shalet, SM | 2 |
| Doeker, B | 1 |
| Müller-Michaels, J | 1 |
| Andler, W | 1 |
| Papadimitriou, A | 2 |
| Preece, MA | 5 |
| Rolland-Cachera, MF | 1 |
| Cavallo, L | 1 |
| Acquafredda, A | 1 |
| Zecchino, C | 1 |
| Delvecchio, M | 1 |
| Moore, DC | 1 |
| Tattoni, DS | 1 |
| Limbeck, GA | 1 |
| Ruvelcaba, RH | 1 |
| Lindner, DS | 1 |
| Gareis, FJ | 1 |
| Al-Agba, S | 1 |
| Hopwood, NJ | 1 |
| Kelch, RP | 1 |
| Zipf, WB | 1 |
| Hernandez, RJ | 1 |
| Crawford, JD | 1 |
| Marti-Henneberg, C | 1 |
| Niirianen, AK | 1 |
| Rappaport, R | 1 |
| Rybakowa, M | 1 |
| Król, W | 1 |
| Krzyzanowska, T | 1 |
| Huseman, C | 1 |
| Johanson, A | 1 |
| Pierson, M | 1 |
| Leheup, B | 1 |
| Ranke, MB | 1 |
| Stahnke, N | 1 |
| Stubbe, P | 1 |
| Keller, E | 1 |
| Haeusler, G | 1 |
| Frisch, H | 1 |
| Rochiccioli, P | 1 |
| Tauber, MT | 1 |
| Loche, S | 3 |
| Pintor, C | 3 |
| Cambiaso, P | 1 |
| Lampis, A | 2 |
| Carta, D | 1 |
| Corda, R | 3 |
| Cappa, M | 1 |
| Wacharasindhu, S | 1 |
| Pearl, K | 1 |
| Rees, L | 1 |
| Rigden, SP | 1 |
| Buyukgebiz, A | 2 |
| Nilsson, KO | 1 |
| Joss, EE | 1 |
| Schmidt, HA | 1 |
| Zuppinger, KA | 1 |
| Ferrández, A | 1 |
| Mayayo, E | 1 |
| Arnal, JM | 1 |
| García, C | 1 |
| Buñuel, C | 1 |
| Lasarte, JJ | 1 |
| Anton, R | 1 |
| Puyuelo, P | 1 |
| Puggioni, R | 1 |
| Cella, SG | 1 |
| Muller, EE | 1 |
| Rusconi, R | 1 |
| Clayton, PE | 1 |
| Price, DA | 1 |
| Addison, GM | 1 |
| Rosenfeld, RG | 1 |
| Buchanan, CR | 1 |
| Fenn, GC | 1 |
| Hindmarsh, P | 1 |
| Holownia, P | 1 |
| Honour, J | 1 |
| Link, K | 1 |
| Blizzard, RM | 1 |
| Evans, WS | 1 |
| Kaiser, DL | 1 |
| Parker, MW | 1 |
| Rogol, AD | 1 |
| Bettmann, HK | 1 |
| Goldman, HS | 1 |
| Abramowicz, M | 1 |
| Sobel, EH | 1 |
| Wright, WC | 1 |
| Siegel, SC | 1 |
| Wong, SR | 1 |
| Jackson, ST | 1 |
| Rallison, ML | 1 |
| Buntin, WH | 1 |
| Johnson, SB | 1 |
| Flynn, RR | 1 |
| Saeed uz Zafar, M | 1 |
| Mellinger, RC | 1 |
| Wolf, C | 1 |
| Morrow, LB | 1 |
| Whitten, C | 1 |
| DeJongh, D | 1 |
| Hills, E | 1 |
| Rosenblum, AL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors[NCT00239668] | 3,000 participants (Anticipated) | Observational | 2000-03-31 | Completed | |||
| Assessment of the Treatment of the Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation[NCT00675714] | Phase 2/Phase 3 | 1,126 participants (Actual) | Interventional | 2004-01-31 | Terminated (stopped due to At the request of the study site, this study has been closed and access to study-related data is unavailable. We are unable to submit the results-data.) | ||
| Comparison of Standard and Physiologic Sex Steroid Replacement Regimens in Women With Premature Ovarian Failure and the Assessment of Skeletal, Cardiovascular and Reproductive Parameters[NCT00732693] | Phase 4 | 42 participants (Actual) | Interventional | 2002-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for oxandrolone and Growth Disorders
| Article | Year |
|---|---|
Clinical practice. Short stature in childhood--challenges and choices.
Topics: Age Determination by Skeleton; Androgens; Body Height; Child; Diagnosis, Differential; Growth; Growt | 2013 |
Novel approaches to short stature therapy.
Topics: Achondroplasia; Androgens; Aromatase Inhibitors; Dwarfism, Pituitary; Gonadotropin-Releasing Hormone | 2015 |
Treatment of the short, sexually immature adolescent boy.
Topics: Adolescent; Anabolic Agents; Growth Disorders; Humans; Male; Oxandrolone; Puberty, Delayed; Testoste | 1994 |
Clinical review 48: The current status of diagnosis and therapeutic intervention in Turner's syndrome.
Topics: Adolescent; Adult; Aortic Coarctation; Calcium, Dietary; Carbohydrate Metabolism, Inborn Errors; Chi | 1993 |
[Turner's syndrome is not what it was in the past].
Topics: Adolescent; Adult; Body Height; Child; Child, Preschool; Developmental Disabilities; Drug Therapy, C | 1992 |
Current concepts in the treatment of Turner syndrome with special reference to the treatment of short stature.
Topics: Age Factors; Body Height; Child; Child, Preschool; Developmental Disabilities; Ethinyl Estradiol; Fe | 1992 |
[Growth hormone treatment in short stature of unknown origin].
Topics: Body Height; Bone Development; Child; Dose-Response Relationship, Drug; Female; Growth; Growth Disor | 1992 |
[Turner's syndrome: a revolution].
Topics: Adolescent; Adult; Body Height; Child; Child, Preschool; Drug Therapy, Combination; Estrogens; Femal | 1992 |
Treatment of growth hormone insufficiency.
Topics: Child; Child, Preschool; Chorionic Gonadotropin; Growth Disorders; Humans; Infant; Noonan Syndrome; | 1990 |
What is the value of growth hormone treatment in short children with specified syndrome? Turner's syndrome, osteochondrodysplasias, Prader-Willi syndrome, Noonan syndrome.
Topics: Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Drug Therapy, Combination; Est | 1989 |
Treatment of short stature and delayed adolescence.
Topics: Adolescent; Body Height; Child; Female; Growth Disorders; Growth Hormone; Humans; Male; Oxandrolone; | 1987 |
17 trials available for oxandrolone and Growth Disorders
| Article | Year |
|---|---|
Reversal of Growth Arrest With the Combined Administration of Oxandrolone and Propranolol in Severely Burned Children.
Topics: Adolescent; Burns; Child; Child, Preschool; Drug Therapy, Combination; Female; Growth; Growth Disord | 2016 |
Reversal of Growth Arrest With the Combined Administration of Oxandrolone and Propranolol in Severely Burned Children.
Topics: Adolescent; Burns; Child; Child, Preschool; Drug Therapy, Combination; Female; Growth; Growth Disord | 2016 |
Reversal of Growth Arrest With the Combined Administration of Oxandrolone and Propranolol in Severely Burned Children.
Topics: Adolescent; Burns; Child; Child, Preschool; Drug Therapy, Combination; Female; Growth; Growth Disord | 2016 |
Reversal of Growth Arrest With the Combined Administration of Oxandrolone and Propranolol in Severely Burned Children.
Topics: Adolescent; Burns; Child; Child, Preschool; Drug Therapy, Combination; Female; Growth; Growth Disord | 2016 |
A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature.
Topics: Adolescent; Androgens; Aromatase Inhibitors; Body Height; Bone Density; Cholesterol; Double-Blind Me | 2010 |
The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome.
Topics: Adolescent; Anabolic Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Estrogens; F | 2011 |
Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial.
Topics: Adolescent; Anabolic Agents; Body Height; Child; Double-Blind Method; Female; Growth Disorders; Huma | 2011 |
Androgen therapy in constitutional delay of growth.
Topics: Adolescent; Androgens; Body Mass Index; Child; Drug Administration Schedule; Growth; Growth Disorder | 2003 |
Effect of growth hormone and oxandrolone singly and together on growth rate in girls with X chromosome abnormalities.
Topics: Adolescent; Age Determination by Skeleton; Body Height; Child; Drug Administration Schedule; Drug Th | 1980 |
Oxandrolone therapy in constitutionally delayed growth and puberty. Bio-Technology General Corporation Cooperative Study Group.
Topics: Adolescent; Anabolic Agents; Child; Double-Blind Method; Growth; Growth Disorders; Humans; Male; Oxa | 1995 |
Oral treatment for constitutional delay of growth and puberty in boys: a randomised trial of an anabolic steroid or testosterone undecanoate.
Topics: Administration, Oral; Adolescent; Anthropometry; Body Height; Bone Development; Child; Growth Disord | 1994 |
Early morning plasma testosterone is an accurate predictor of imminent pubertal development in prepubertal boys.
Topics: Adolescent; Biomarkers; Child; Circadian Rhythm; Cohort Studies; Follow-Up Studies; Growth Disorders | 1993 |
Effect of low dose oxandrolone and testosterone treatment on the pituitary-testicular and GH axes in boys with constitutional delay of growth and puberty.
Topics: Adolescent; Anabolic Agents; Double-Blind Method; Drug Administration Schedule; Growth Disorders; Gr | 1997 |
Recombinant human growth hormone and oxandrolone in treatment of short stature in girls with Turner syndrome.
Topics: Aging; Body Height; Body Weight; Bone Development; Child; Female; Growth Disorders; Growth Hormone; | 1992 |
The effect of short-term growth hormone or low-dose oxandrolone treatment in boys with constitutional growth delay.
Topics: Adolescent; Body Height; Child; Growth Disorders; Growth Hormone; Humans; Insulin-Like Growth Factor | 1991 |
Treatment of constitutional growth delay in prepubertal boys with a prolonged course of low dose oxandrolone.
Topics: Adolescent; Body Height; Child; Drug Administration Schedule; Growth Disorders; Humans; Male; Oxandr | 1991 |
Treatment of constitutional delay of growth and puberty with oxandrolone compared with growth hormone.
Topics: Adolescent; Growth Disorders; Growth Hormone; Hormones; Humans; Male; Oxandrolone; Puberty, Delayed | 1990 |
Growth and growth hormone responses to oxandrolone in boys with constitutional delay of growth and puberty (CDGP).
Topics: Adolescent; Child; Growth; Growth Disorders; Growth Hormone; Humans; Insulin-Like Growth Factor I; M | 1988 |
Double blind placebo controlled trial of low dose oxandrolone in the treatment of boys with constitutional delay of growth and puberty.
Topics: Adolescent; Child; Double-Blind Method; Growth Disorders; Humans; Insulin-Like Growth Factor I; Male | 1988 |
Nitrogen metabolism in growth hormone-deficient children receiving oxandrolone and human growth hormone.
Topics: Arginine; Body Height; Bone Development; Child; Clinical Trials as Topic; Diet; Drug Synergism; Drug | 1974 |
39 other studies available for oxandrolone and Growth Disorders
| Article | Year |
|---|---|
Turner syndrome: searching for better outcomes.
Topics: Anabolic Agents; Body Height; Child; Cohort Studies; Estrogen Replacement Therapy; Female; Follow-Up | 2008 |
[Therapy of Turner's syndrome with oxandrolone].
Topics: Adolescent; Child; Female; Growth Disorders; Humans; Male; Oxandrolone; Turner Syndrome | 1983 |
Focal nodular hyperplasia associated with the use of a synthetic anabolic androgen.
Topics: Child; Growth Disorders; Humans; Hyperplasia; Liver; Male; Oxandrolone | 1984 |
Use of anabolic agents in treatment of short children.
Topics: Body Height; Child; Child, Preschool; Follow-Up Studies; Growth Disorders; Growth Hormone; Humans; O | 1982 |
[Treatment of constitutional developmental retardation with oxandrolone].
Topics: Adolescent; Age Determination by Skeleton; Body Height; Bone Development; Child; Child, Preschool; F | 1981 |
The combined effect of growth hormone and oxandrolone in patients with growth hormone deficiency.
Topics: Adolescent; Age Determination by Skeleton; Body Height; Child; Child, Preschool; Drug Administration | 1980 |
The effects of anabolic steroids on growth, body composition, and metabolism in boys with chronic renal failure on regular hemodialysis.
Topics: Adolescent; Basal Metabolism; Body Composition; Bone Development; Child; Growth; Growth Disorders; H | 1980 |
Predictive factors in the determination of final height in boys with constitutional delay of growth and puberty.
Topics: Adolescent; Analysis of Variance; Anthropometry; Body Height; Child; Growth Disorders; Humans; Male; | 1995 |
Short stature.
Topics: Adolescent; Child; Cushing Syndrome; Female; Growth Disorders; Growth Hormone; Humans; Hypothyroidis | 1994 |
Treatment of growth delay in boys with isolated growth hormone deficiency.
Topics: Adolescent; Body Height; Bone Development; Child; Growth Disorders; Growth Hormone; Humans; Male; Ox | 1994 |
The effects of oxandrolone on the growth hormone and gonadal axes in boys with constitutional delay of growth and puberty.
Topics: Adolescent; Child; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Depression, Chemical; Fol | 1993 |
Oxandrolone in constitutional delay of growth: analysis of the growth patterns up to final stature.
Topics: Adolescent; Body Height; Bone Development; Child; Growth Disorders; Humans; Male; Oxandrolone; Puber | 1993 |
The effect of prolonged administration of an anabolic steroid (oxandrolone) on growth in boys with constitutionally delayed growth and puberty.
Topics: Adolescent; Anabolic Agents; Analysis of Variance; Body Height; Case-Control Studies; Growth; Growth | 1995 |
Induction of early puberty in a boy after treatment with oxandrolone?
Topics: Age Determination by Skeleton; Anabolic Agents; Bone Development; Child; Growth Disorders; Humans; M | 1998 |
The anabolic steroid oxandrolone increases muscle mass in prepubertal boys with constitutional delay of growth.
Topics: Anabolic Agents; Anthropometry; Body Composition; Body Height; Body Mass Index; Child; Growth Disord | 2001 |
[Constitutional delay of growth and puberty].
Topics: Adolescent; Age Factors; Anabolic Agents; Child; Female; Gonadal Steroid Hormones; Growth Disorders; | 2001 |
Studies of anabolic steroids: v. effect of prolonged oxandrolone administration on growth in children and adolescents with uncomplicated short stature.
Topics: Adolescent; Age Determination by Skeleton; Age Factors; Body Height; Child; Child, Preschool; Chrono | 1976 |
The effect of synthetic androgens on the hypothalamic-pituitary-gonadal axis in boys with constitutionally delayed growth.
Topics: Adolescent; Child; Fluoxymesterone; Follicle Stimulating Hormone; Growth Disorders; Humans; Hypothal | 1979 |
Management of children with Turner's syndrome.
Topics: Adolescent; Child; Estrogens; Female; Growth Disorders; Heart Defects, Congenital; Humans; Keloid; O | 1979 |
Oxandrolone treatment of constitutional short stature in boys during adolescence: effect on linear growth, bone age, pubic hair, and testicular development.
Topics: Adolescent; Body Height; Bone Development; Child; Drug Evaluation; Growth; Growth Disorders; Hair; H | 1975 |
[Effect of oxandrolone on body height and skeletal maturation in some growth disorders in children].
Topics: Adolescent; Age Factors; Body Height; Child; Child, Preschool; Female; Growth Disorders; Humans; Mal | 1975 |
Growth hormone deficiency in anorexia nervosa.
Topics: Anorexia Nervosa; Child; Female; Growth Disorders; Growth Hormone; Humans; Hypopituitarism; Levodopa | 1975 |
Growth hormone treatment in Turner's syndrome: short and long-term effects on metabolic parameters.
Topics: Adolescent; Bone Development; Child; Drug Therapy, Combination; Ethinyl Estradiol; Fatty Acids, None | 1992 |
The influence of steroid therapy and recombinant human erythropoietin on the growth of children with renal disease.
Topics: Adolescent; Anemia; Child; Child, Preschool; Erythropoietin; Growth; Growth Disorders; Growth Hormon | 1991 |
Long-term outcome of oxandrolone treatment in boys with constitutional delay of growth and puberty.
Topics: Adolescent; Body Height; Child; Genitalia, Male; Growth Disorders; Humans; Male; Oxandrolone; Pubert | 1990 |
Oxandrolone in constitutionally delayed growth, a longitudinal study up to final height.
Topics: Body Height; Child; Female; Growth Disorders; Humans; Longitudinal Studies; Male; Oxandrolone | 1989 |
Effect of recombinant human growth hormone therapy on bone and clinical parameters in girls with Turner's syndrome. The Spanish Collaborative Group.
Topics: Adolescent; Bone Development; Child; Child, Preschool; Drug Therapy, Combination; Ethinyl Estradiol; | 1989 |
The effect of oxandrolone on the growth hormone response to growth hormone releasing hormone in children with constitutional growth delay.
Topics: Adolescent; Child; Female; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Human | 1986 |
[Considerations on forecasting [corrected] growth after cessation of oxandrolone therapy.
Topics: Adolescent; Age Factors; Child; Growth; Growth Disorders; Humans; Male; Oxandrolone; Prognosis; Time | 1988 |
Oxandrolone induces a sustained rise in physiological growth hormone secretion in boys with constitutional delay of growth and puberty.
Topics: Adolescent; Body Constitution; Growth Disorders; Growth Hormone; Humans; Luteinizing Hormone; Male; | 1987 |
Sex steroids and somatomedin C.
Topics: Adolescent; Child; Growth Disorders; Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Oxa | 1986 |
The effect of androgens on the pulsatile release and the twenty-four-hour mean concentration of growth hormone in peripubertal males.
Topics: Adolescent; Child; Circadian Rhythm; Growth Disorders; Growth Hormone; Humans; Insulin-Like Growth F | 1986 |
Oxandrolone in low dose for constitutional delay of growth and puberty in boys.
Topics: Adolescent; Child; Drug Administration Schedule; Growth Disorders; Humans; Male; Oxandrolone; Pubert | 1985 |
Oxandrolone in low dose for constitutional delay of growth and puberty in boys.
Topics: Adolescent; Growth Disorders; Humans; Male; Oxandrolone; Puberty, Delayed; Research Design | 1985 |
Oxandrolone treatment of short stature: effect on predicted mature height.
Topics: Adolescent; Age Determination by Skeleton; Body Height; Body Weight; Bone Development; Child; Child, | 1971 |
Effects of synthetic ACTH on corticosteroid-induced growth suppression.
Topics: Adolescent; Adrenocorticotropic Hormone; Asthma; Growth Disorders; Humans; Male; Oxandrolone; Predni | 1974 |
Use of oxandrolone for growth stimulation in children.
Topics: Administration, Oral; Adolescent; Age Determination by Skeleton; Age Factors; Body Height; Bone Deve | 1973 |
American Academy of Pediatrics. Committee on Drugs. Counseling and synthetic steroids in short stature without organic disease.
Topics: Adaptation, Psychological; Adolescent; Body Height; Body Weight; Child; Counseling; Female; Fluoxyme | 1974 |
Letter: Oxandrolone for growth stimulation.
Topics: Body Height; Female; Growth Disorders; Humans; Male; Oxandrolone; Turner Syndrome | 1974 |